Alexander Seyf | Autolumos

How do we take cell and gene therapies from boutique, ultra-rare treatments to scalable, mainstream medicine?

In this episode of Partner.bio at BIO 2026, we connect with Alexander Seyf, the multidisciplinary mind behind Autolumos. With a background spanning mathematics, physics, astronomy, and early artificial intelligence, Alexander brings a unique, systems-level perspective to the biotech sector.

In this interview, he breaks down the critical manufacturing barriers holding back advanced therapeutics and why a digital revolution is no longer optional for the life sciences industry.